If you're on insulin or sulfonylureas, pre-meal cagrilintide dosing can increase hypoglycemia risk
Since lowering blood glucose level reduces oxidative stress [8, 9], the reduced risk of microvascular complications may be partially due to improved antioxidant capacity
In: Hossain, M., Wani, S., Bhattacharjee, S., Burritt, D., Tran, LS
L.Carter-SuC
Injection-site risk: Any subcutaneous injection carries risk of local infection, bruising, and lipodystrophy with repeated use at the same site
According to Todd Carter, chief scientific officer at Voyager Therapeutics, which is developing a small interfering RNA gene therapy to stop tau production, there was no reason to anticipate that blocking tau protein synthesis would impact the stability of the existing protein